Sort   by:  
 Page size 
UnknownDifferential roles for cryptochromes in the mammalian retinal clock.
Not available
S-EPMC6071063 | biostudies-literature
UnknownAn Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK.
Not available
S-EPMC7089725 | biostudies-literature
UnknownAbsence of Neuroplastin-65 Affects Synaptogenesis in Mouse Inner Hair Cells and Causes Profound Hearing Loss.
Not available
S-EPMC4701962 | biostudies-literature
UnknownDetailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.
Not available
S-EPMC5710208 | biostudies-literature
UnknownInterim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations.
Not available
S-EPMC5572402 | biostudies-literature
UnknownThe T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
Not available
S-EPMC3857251 | biostudies-literature
UnknownXOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with <i>Retinitis Pigmentosa GTPase Regulator</i>-Associated X-Linked Retinitis Pigmentosa.
Not available
S-EPMC11531613 | biostudies-literature
UnknownChanges in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
Not available
S-EPMC9912164 | biostudies-literature
UnknownComprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease.
Not available
S-EPMC5223092 | biostudies-literature
UnknownReal-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study.
Not available
S-EPMC10813228 | biostudies-literature
Sort   by:  
 Page size